FULGENT GENETICS, INC. Lessor, Operating Lease, Payment to be Received, Year One
FULGENT GENETICS, INC. (FLGT) had Lessor, Operating Lease, Payment to be Received, Year One of $90.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Notes › Leases › Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity
us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths · last filed 2024-02-28
- 2023-12-31: Lessor, Operating Lease, Payment to be Received, Year One $90.00K.
- 2023-09-30: Lessor, Operating Lease, Payment to be Received, Year One $90.00K.
- 2023-06-30: Lessor, Operating Lease, Payment to be Received, Year One $91.00K.
- 2023-03-31: Lessor, Operating Lease, Payment to be Received, Year One $94.00K.
| Period end | Lessor, Operating Lease, Payment to be Received, Year One |
|---|---|
| 2023-12-31 | $90.00K 10-K · filed 2024-02-28 |
| 2023-09-30 | $90.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $91.00K 10-Q · filed 2023-08-04 |
| 2023-03-31 | $94.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $181.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $93.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $264.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $264.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $355.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $356.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $190.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $190.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $335.00K 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |